Table 1.
UNMATCHED | MATCHED | |||||
---|---|---|---|---|---|---|
SuRD-AVR (n = 636) | TAVI (n = 670) | p-Value | SuRD-AVR (n = 346) | TAVI (n = 346) | p-Value | |
Age (years), median (IQR) | 78 (74–81) | 81 (77–84) | <0.001 | 79 (76–83) | 80 (76–84) | 0.266 |
Gender (female) | 364 (57.2%) | 312 (46.6%) | <0.001 | 186 (53.8%) | 189 (54.6%) | 0.819 |
Body mass index (kg/m2) | 27.1 ± 4.6 | 27.2 ± 4.3 | 0.642 | 26.9 ± 4.7 | 27.2 ± 4.9 | 0.069 |
Body surface area (m2), median (IQR) | 1.81 ± 0.2 | 1.82 ± 0.2 | 0.773 | 1.81 ± 0.2 | 1.81 ± 0.2 | 0.923 |
EuroSCORE II (%), median (IQR) | 2.0 (1.4–2.8) | 3.0 (2.3–3.5) | <0.001 | 2.6 (1.9–3.2) | 2.5 (2.0–3.1) | 0.977 |
Hypertension(mmHg) | 532 (83.6%) | 566 (84.5%) | 0.682 | 282 (81.5%) | 291 (84.1%) | 0.365 |
Dyslipidaemia | 428 (67.3%) | 359 (53.6%) | <0.001 | 196 (56.6%) | 195 (56.4%) | 0.939 |
Diabetes Mellitus | 208 (32.7%) | 141 (21.0%) | <0.001 | 92 (26.6%) | 83 (24.0%) | 0.431 |
Advance NYHA (class III–IV) | 253 (39.8%) | 257 (38.4%) | 0.598 | 79 (22.8%) | 82 (23.7%) | 0.787 |
COPD (FEV1 < 60%) | 69 (10.8%) | 93 (13.9%) | 0.097 | 46 (13.3%) | 49 (14.2%) | 0.740 |
Previous CVA | 50 (7.9%) | 45 (6.7%) | 0.426 | 21 (6.1%) | 16 (4.6%) | 0.398 |
Atrial fibrillation | 63 (9.9%) | 63 (9.4%) | 0.758 | 36 (10.4%) | 30 (8.7%) | 0.437 |
Pulmonary hypertension (>30 mmHg) | 179 (28.1%) | 228 (34%) | 0.022 | 114 (32.9%) | 112 (32.4%) | 0.871 |
Peripherical arterial disease | 68 (10.7%) | 67 (10%) | 0.681 | 35 (10.1%) | 31 (9.0%) | 0.604 |
Previous Cardiac Surgery | 12 (1.9%) | 152 (22.7%) | <0.001 | 12 (3.5%) | 17 (4.9%) | 0.343 |
Frailty | 19 (2.9%) | 33 (4.9%) | 0.073 | 10 (2.8%) | 15 (4.3%) | 0.308 |
Creatinine (mg/dL), mean ± SD | 0.95 ± 0.5 | 1.15 ± 0.6 | <0.001 | 1.01 ± 0.7 | 1.06 ± 0.6 | 0.324 |
Sievers Type 1 Bicupid valve | 44 (6.7%) | 7 (1%) | <0.001 | 6 (1.7%) | 5 (1.4%) | 0.761 |
SAA | 111 (17.4%) | 139 (20.7%) | 0.130 | 67 (19.3%) | 86 (24.8%) | 0.081 |
Left ventricular ejection fraction, mean ± SD | 57.7 ± 6 | 57.7 ± 7 | 0.478 | 57.6 ± 6 | 56.4 ± 7 | 0.231 |
NYHA: New York Heart Association; COPD: Chronic Obstructive Pulmonary Disease; SAA: Small Aortic Annulus.